DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-429 Cr |
| Mar2024 | ₹-974 Cr |
| Mar2023 | ₹-629 Cr |
| Mar2022 | ₹-1,276 Cr |
| Mar2021 | ₹-1,040 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-429 Cr | Negative | |
| Mar2024 | ₹-974 Cr | Negative | |
| Mar2023 | ₹-629 Cr | Negative | |
| Mar2022 | ₹-1,276 Cr | Negative | |
| Mar2021 | ₹-1,040 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹101,633.1 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
| MANKIND PHARMA | ₹82,460.4 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -6.5% |
-5.4% |
3.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses